Literature DB >> 28858416

Response to: HCV viremic donors with hepatic bridging fibrosis: Are we ready to use their livers in the era of direct-acting antivirals?

J Levitsky1, R N Formica2.   

Abstract

Entities:  

Keywords:  clinical decision-making; clinical research/practice; infection and infectious agents - viral: hepatitis C; liver transplantation/hepatology

Mesh：

Substances：

Year:  2017        PMID： 28858416     DOI： 10.1111/ajt.14478

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  1 in total

Review 1.  Usage of HCV viremic organs in liver transplantation to anti-HCV negative recipients: The current status and review of literature.

Authors:  Aslı Çiftçibaşı Örmeci; Çağla Yıldız; Behnam Saberi; Merve Gürakar; Cem Şimşek; Ahmet Gürakar
Journal:  Turk J Gastroenterol       Date:  2019-09       Impact factor: 1.852
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.